Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Long-term bosentan therapy attenuates progression of LV dysfunction and remodeling in heart failure

March 9, 2000

Injectable carvedilol formulations successfully developed

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

AGE crosslink breaker effective in nondiabetic animals with myocardial stiffness

March 9, 2000

Medicure receives second U.S. patent for cardiovascular drug

March 9, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

Macrophage scavenger receptor antagonists under study at SB

March 7, 2000

Statin inhibits VSMC proliferation, reduces neointimal formation after vascular injury

March 6, 2000

MMP inhibitors from Warner-Lambert particularly active against MMP-2, MMP-3 and MMP-13

March 3, 2000

Large valsartan trial reaches enrollment objectives

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...